Patents Assigned to Plus Therapeutics, Inc.
  • RADIOLABELED LIPOSOMES AND METHODS OF USE THEREOF
    Publication number: 20220273832
    Abstract: Radiolabeled liposomes can be used in the treatment of cancer. These local therapies can be used to treat cancers including, but not limited to, lung cancer, breast cancer, colorectal cancer, prostate cancer, skin cancer, stomach cancer, bladder cancer, liver cancer, leukemia, lymphoma, ovarian cancer, pancreatic cancer, hepatocellular carcinoma, melanoma, sarcoma, head and neck cancer, glioma, glioblastoma, medulloblastoma, ependymoma, diffuse intrinsic pontine glioma, leptomeningeal metastases, and pediatric high-grade glioma.
    Type: Application
    Filed: May 17, 2022
    Publication date: September 1, 2022
    Applicants: Plus Therapeutics, Inc., NanoTx, Corp.
    Inventors: Gregory D. Stein, Marc Hedrick, Cheryl Rice, Andrew Brenner, Ande Bao, William Phillips